Emerging Asia HC Illiquid Private Fund

The Crossover Healthcare Emerging Asia Illiquid Fund LP (the "Illiquid Fund") seeks to deliver high risk adjusted returns with low correlations to broader markets and sector specific indices or ETFs by providing diversified regional exposure to investment opportunities in the healthcare sector in Developed and Emerging Asian Markets (ex-China) and the off market Private Equity transactions in the United States. The Fund seeks to identify private, illiquid public, distressed, and special situations healthcare investments that fit within the context of the firm’s multi-disciplinary approach. The Illiquid Fund is structured as a traditional private equity fund with a six-year fund life, eighteen month subscription period, eighteen month investment period and European waterfall.